Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7647331rdf:typepubmed:Citationlld:pubmed
pubmed-article:7647331lifeskim:mentionsumls-concept:C0014912lld:lifeskim
pubmed-article:7647331lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:7647331lifeskim:mentionsumls-concept:C1512505lld:lifeskim
pubmed-article:7647331lifeskim:mentionsumls-concept:C0010961lld:lifeskim
pubmed-article:7647331lifeskim:mentionsumls-concept:C0014930lld:lifeskim
pubmed-article:7647331lifeskim:mentionsumls-concept:C0014942lld:lifeskim
pubmed-article:7647331lifeskim:mentionsumls-concept:C0033401lld:lifeskim
pubmed-article:7647331lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7647331lifeskim:mentionsumls-concept:C0878080lld:lifeskim
pubmed-article:7647331pubmed:issue2lld:pubmed
pubmed-article:7647331pubmed:dateCreated1995-9-25lld:pubmed
pubmed-article:7647331pubmed:abstractTextUsing different hormone-dependent (MCF-7, T-47D) and hormone-independent (MDA-MB-231, Hs-578S, MDA-MB-436) human breast cancer cells, the interconversion estrone (E1)<-->estradiol (E2) was explored. The data show very clearly that in the hormone-dependent cells the tendency is to form E2 after incubation with E1, whereas after incubation with E2 most of this estrogen remains unchanged. In the hormone-independent cells, in contrast most of E1 remains E1, while E2 is converted into E1. The tendency of the reductive<-->oxidative direction is supported by the analysis of estrogens in the culture medium. To explore the possible action of different drugs on the 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) activity, it was observed that the potent antiestrogen ICI 164,384 inhibits the conversion of E1 to E2, while a lesser effect is observed with Danazol and only weak inhibition is obtained with the progestagen Promegestone (R-5020). It is concluded that the orientation of 17 beta-HSD activity for the interconversion E1<-->E2 in hormone-dependent and -independent cells is related to the hormonal status of the cells.lld:pubmed
pubmed-article:7647331pubmed:languageenglld:pubmed
pubmed-article:7647331pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647331pubmed:citationSubsetIMlld:pubmed
pubmed-article:7647331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7647331pubmed:statusMEDLINElld:pubmed
pubmed-article:7647331pubmed:monthMaylld:pubmed
pubmed-article:7647331pubmed:issn0167-6806lld:pubmed
pubmed-article:7647331pubmed:authorpubmed-author:PasqualiniJ...lld:pubmed
pubmed-article:7647331pubmed:authorpubmed-author:NguyenB LBLlld:pubmed
pubmed-article:7647331pubmed:authorpubmed-author:ChetriteGGlld:pubmed
pubmed-article:7647331pubmed:issnTypePrintlld:pubmed
pubmed-article:7647331pubmed:volume34lld:pubmed
pubmed-article:7647331pubmed:ownerNLMlld:pubmed
pubmed-article:7647331pubmed:authorsCompleteYlld:pubmed
pubmed-article:7647331pubmed:pagination139-46lld:pubmed
pubmed-article:7647331pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:meshHeadingpubmed-meshheading:7647331-...lld:pubmed
pubmed-article:7647331pubmed:year1995lld:pubmed
pubmed-article:7647331pubmed:articleTitleTransformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).lld:pubmed
pubmed-article:7647331pubmed:affiliationC.N.R.S. Steroid Hormone Research Unit, Paris, France.lld:pubmed
pubmed-article:7647331pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7647331pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7647331pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7647331lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7647331lld:pubmed